A major risk factor for adverse outcomes was the presence of inflammation in the period before the COVID-19 suspicion date when expressed as both an increased neutrophil-to-lymphocyte ratio (e.g., white blood cell (WBC) factor in our analysis) and C-reactive protein, a finding consistent with previous studies of COVID-19-related mortality in the general population (16). This evidence concerns the gene CRP and COVID-19.